- Home
- GRWG vs LUNG Comparison
GRWG vs LUNG Comparison
Compare GRWG & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRWG | LUNG |
|---|---|---|
| Founded | 2008 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.2M | 72.2M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GRWG | LUNG |
|---|---|---|
| Price | $1.13 | $1.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $2.50 | ★ $5.38 |
| AVG Volume (30 Days) | 352.7K | ★ 727.7K |
| Earning Date | 03-19-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.22 | 7.64 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $193,365,479.00 | $90,497,000.00 |
| Revenue This Year | $7.52 | $2.48 |
| Revenue Next Year | N/A | $18.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 142.51 | 8.01 |
| 52 Week Low | $0.83 | $1.28 |
| 52 Week High | $2.40 | $7.05 |
Technical Indicators
Market Signals| Indicator | GRWG | LUNG |
|---|---|---|
| Relative Strength Index (RSI) | 46.42 | 35.67 |
| Support Level | $1.06 | N/A |
| Resistance Level | $1.19 | $1.93 |
| Average True Range (ATR) | 0.07 | 0.15 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 46.81 | 0.57 |
Price Performance
Historical ComparisonAbout GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.